APA (7th ed.) Citation

Rashidghamat, E., Kadiyirire, T., Ayis, S., Petrof, G., Liu, L., Pullabhatla, V., . . . McGrath, J. A. (2020). Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. Journal of the American Academy of Dermatology, 83(2), 447-454. https://doi.org/10.1016/j.jaad.2019.11.038

Chicago Style (17th ed.) Citation

Rashidghamat, Ellie, et al. "Phase I/II Open-label Trial of Intravenous Allogeneic Mesenchymal Stromal Cell Therapy in Adults with Recessive Dystrophic Epidermolysis Bullosa." Journal of the American Academy of Dermatology 83, no. 2 (2020): 447-454. https://doi.org/10.1016/j.jaad.2019.11.038.

MLA (9th ed.) Citation

Rashidghamat, Ellie, et al. "Phase I/II Open-label Trial of Intravenous Allogeneic Mesenchymal Stromal Cell Therapy in Adults with Recessive Dystrophic Epidermolysis Bullosa." Journal of the American Academy of Dermatology, vol. 83, no. 2, 2020, pp. 447-454, https://doi.org/10.1016/j.jaad.2019.11.038.